Trial intelligence / Profile preview

Intranasal dexmedetomidine vs oral chloral hydrate for pre-examination sedation in children

ChiCTR2600126783Phase 4Not yet recruiting

Sponsor
Affiliated Hospital of Southwest Medical University
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoint: Sedation success rate. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on ChiCTR2600126783.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600126783.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call